|
GB1250719A
(cg-RX-API-DMAC7.html)
|
1969-03-19 |
1971-10-20 |
|
|
|
US4556660A
(en)
|
1982-07-12 |
1985-12-03 |
Janssen Pharmaceutica N.V. |
N-(Bicyclic heterocyclyl)-4-piperidinamines
|
|
DK139684A
(da)
|
1983-04-11 |
1984-10-12 |
Janssen Pharmaceutica Nv |
N-aryl-alpha-amino-carboxamider
|
|
US4634704A
(en)
|
1983-10-06 |
1987-01-06 |
Janssen Pharmaceutica, N.V. |
Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
|
|
US4588722A
(en)
|
1984-01-09 |
1986-05-13 |
Janssen Pharmaceutica N.V. |
N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
|
|
PH23995A
(en)
|
1984-01-09 |
1990-02-09 |
Janssen Pharmaceutica Nv |
4((bicycle heterocyclyl)-methyl and hetero)piperidines
|
|
US4695575A
(en)
*
|
1984-11-13 |
1987-09-22 |
Janssen Pharmaceutica, N.V. |
4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
|
|
JPH07501063A
(ja)
|
1991-11-14 |
1995-02-02 |
グラクソ、グループ、リミテッド |
フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体
|
|
GB9319534D0
(en)
*
|
1993-09-22 |
1993-11-10 |
Boots Co Plc |
Therapeutic agents
|
|
IL117149A0
(en)
*
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
|
US5889006A
(en)
*
|
1995-02-23 |
1999-03-30 |
Schering Corporation |
Muscarinic antagonists
|
|
US5696267A
(en)
|
1995-05-02 |
1997-12-09 |
Schering Corporation |
Substituted oximes, hydrazones and olefins as neurokinin antagonists
|
|
WO1996041631A1
(en)
*
|
1995-06-09 |
1996-12-27 |
Eli Lilly And Company |
Methods of treating cold and allergic rhinitis
|
|
TW531537B
(en)
|
1995-12-27 |
2003-05-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
|
|
US5952349A
(en)
*
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
ATE227708T1
(de)
|
1996-07-10 |
2002-11-15 |
Schering Corp |
1,4-disubstituierte piperdine als muskarin- antagonisten
|
|
EP0821954A1
(en)
|
1996-08-01 |
1998-02-04 |
Eli Lilly And Company |
Method for treating mental retardation
|
|
US5977138A
(en)
*
|
1996-08-15 |
1999-11-02 |
Schering Corporation |
Ether muscarinic antagonists
|
|
HUP9904363A3
(en)
|
1996-08-15 |
2000-12-28 |
Schering Corp |
Piperidine ether muscarinic antagonists and pharmaceutical compositions containing them
|
|
DE59711622D1
(de)
|
1996-09-10 |
2004-06-17 |
Boehringer Ingelheim Pharma |
Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
EP1003514A4
(en)
|
1997-07-25 |
2000-10-11 |
Merck & Co Inc |
CYCLIC AMINE MODULATORS OF CHEMOKIN RECEPTORS
|
|
YU47600A
(sh)
|
1998-01-27 |
2002-09-19 |
Aventis Pharmaceuticals Products Inc. |
SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa
|
|
EP1052992A1
(en)
|
1998-02-02 |
2000-11-22 |
Merck & Co., Inc. |
Cyclic amine modulators of chemokine receptor activity
|
|
TWI245763B
(en)
|
1998-04-02 |
2005-12-21 |
Janssen Pharmaceutica Nv |
Biocidal benzylbiphenyl derivatives
|
|
KR20010043032A
(ko)
|
1998-04-28 |
2001-05-25 |
도모따께 다께시 |
1-[(1-치환-4-피페리디닐)메틸]-4-피페리딘 유도체, 그의제조방법, 그것을 함유하는의약조성물 및 이 화합물의중간체
|
|
US6066636A
(en)
*
|
1998-06-30 |
2000-05-23 |
Schering Corporation |
Muscarinic antagonists
|
|
WO2000000488A1
(en)
|
1998-06-30 |
2000-01-06 |
Schering Corporation |
Muscarinic antagonists
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
JP2003529531A
(ja)
|
1998-11-25 |
2003-10-07 |
アヴェンティス ファーマシューティカルズ インコーポレイテッド |
置換オキソアザへテロシクリルXa因子阻害剤
|
|
US6331545B1
(en)
*
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
Heterocycyclic piperidines as modulators of chemokine receptor activity
|
|
US6387930B1
(en)
*
|
1999-05-04 |
2002-05-14 |
Schering Corporation |
Piperidine derivatives useful as CCR5 antagonists
|
|
PL203117B1
(pl)
|
1999-05-04 |
2009-08-31 |
Schering Corp |
Piperydynopiperydynowa pochodna użyteczna jako antagonista CCR5, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
|
|
SE9902551D0
(sv)
|
1999-07-02 |
1999-07-02 |
Astra Pharma Prod |
Novel compounds
|
|
KR20020087041A
(ko)
|
1999-07-28 |
2002-11-21 |
아벤티스 파마슈티칼스 프로덕츠 인크. |
치환된 옥소아자헤테로사이클릴 화합물
|
|
US6294554B1
(en)
*
|
1999-09-22 |
2001-09-25 |
Schering Corporation |
Muscarinic antagonists
|
|
IT1307809B1
(it)
|
1999-10-21 |
2001-11-19 |
Menarini Ricerche Spa |
Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
|
|
AR033517A1
(es)
*
|
2000-04-08 |
2003-12-26 |
Astrazeneca Ab |
Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
|
|
GB0013060D0
(en)
|
2000-05-31 |
2000-07-19 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2002018335A1
(en)
|
2000-08-28 |
2002-03-07 |
Yamanouchi Pharmaceutical Co., Ltd. |
Cyclic amine derivatives
|
|
GB0021670D0
(en)
|
2000-09-04 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
JP4522651B2
(ja)
|
2001-03-13 |
2010-08-11 |
シェーリング コーポレイション |
新規非イミダゾール化合物
|
|
ATE466009T1
(de)
|
2001-03-29 |
2010-05-15 |
Schering Corp |
Ccr5 antagonisten verwendbar für die behandlung von aids
|
|
GB0107907D0
(en)
|
2001-03-29 |
2001-05-23 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0108876D0
(en)
|
2001-04-09 |
2001-05-30 |
Novartis Ag |
Organic Compounds
|
|
DE60209736T2
(de)
*
|
2001-07-02 |
2006-11-02 |
Astrazeneca Ab |
Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen
|
|
GB0117899D0
(en)
*
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0120461D0
(en)
|
2001-08-22 |
2001-10-17 |
Astrazeneca Ab |
Novel compounds
|
|
AR036366A1
(es)
|
2001-08-29 |
2004-09-01 |
Schering Corp |
Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
|
|
GB0122503D0
(en)
|
2001-09-18 |
2001-11-07 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0200843D0
(sv)
*
|
2002-03-19 |
2002-03-19 |
Astrazeneca Ab |
Chemical compounds
|
|
US6696468B2
(en)
|
2002-05-16 |
2004-02-24 |
Dainippon Pharmaceutical Co., Ltd. |
(s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
|
|
SE0202838D0
(sv)
|
2002-09-24 |
2002-09-24 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0300850D0
(sv)
*
|
2003-03-25 |
2003-03-25 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0300957D0
(sv)
|
2003-04-01 |
2003-04-01 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1633737A1
(en)
|
2003-06-13 |
2006-03-15 |
Schering Aktiengesellschaft |
Quinolyl amide derivatives as ccr-5 antagonists
|
|
SE0400925D0
(sv)
|
2004-04-06 |
2004-04-06 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1888527A1
(en)
|
2005-05-27 |
2008-02-20 |
AstraZeneca AB |
Piperidines for the treatment of chemokine mediated diseases
|
|
TW200722419A
(en)
|
2005-05-27 |
2007-06-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2615650A1
(en)
|
2005-07-21 |
2007-01-25 |
Astrazeneca Ab |
Novel piperidine derivatives
|